| Announce Date | 11/03/2025 |
| EPS Normalized Actual | $1.56 (Beat by $0.03) |
| EPS GAAP Actual | $1.56 (Beat by $0.03) |
| Revenue Actual | $0.362301B |
| Revenue Surprise | Beat by $362.301M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.37 |
| EPS GAAP Estimate | $1.37 |
| Revenue Estimate | $0.30167406B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 7.66 | 14.76 | 7.4143 | 8.17942 | 1 |
| Dec 2027 | 7.56 | 14.96 | 7.42555 | 7.73865 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.22 | -0.115 | 0.362301B | 20.01% | 63.33M |
| FQ2 2025 (Jun 2025) | 1.2 | -0.1125 | 0.349443B | 17.89% | 49.74M |
| FQ1 2025 (Mar 2025) | 1.16 | 1.16 | 0.337708B | 16.87% | 337.71M |
| FQ4 2024 (Dec 2024) | 1.07 | 1.07 | 0.297144B | 7% | 297.14M |
| FQ3 2024 (Sep 2024) | 1.18 | 1.18 | 0.289787B | 6.58% | 289.79M |
| FQ2 2024 (Jun 2024) | 1.12 | 1.12 | 0.286922B | 9.39% | 286.92M |
| FQ1 2024 (Mar 2024) | 0.99 | 0.99 | 0.280746B | 10.38% | 280.75M |
| FQ4 2023 (Dec 2023) | 1.2 | 1.2 | 0.276351B | 10.6% | 276.35M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.37
Consensus Revenue Estimates
0.30167406B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.10672 | -- | 2.09322 | 2.13191 | 2 |
| FQ3 2027 (Sep 2027) | 1.8568 | -- | 1.79843 | 1.949 | 2 |
| FQ2 2027 (Jun 2027) | 1.86169 | -- | 1.80317 | 1.95413 | 2 |
| FQ1 2027 (Mar 2027) | 1.66976 | -- | 1.61727 | 1.75267 | 2 |
| FQ4 2026 (Oct 2026) | 1.48 | -- | 1.46693 | 1.49861 | 3 |
| FQ3 2026 (Jul 2026) | 1.46 | 16.44 | 1.44711 | 1.47836 | 3 |
| FQ2 2026 (Jun 2026) | 1.59475 | 24.75 | 1.51977 | 1.642 | 2 |
| FQ1 2026 (Mar 2026) | 1.46669 | 20.91 | 1.39773 | 1.51014 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.45B | -- | 0.45B | 0.45B | 6 |
| FQ3 2027 (Sep 2027) | 0.44B | -- | 0.43B | 0.46B | 3 |
| FQ2 2027 (Jun 2027) | 0.43B | -- | 0.42B | 0.45B | 3 |
| FQ1 2027 (Mar 2027) | 0.42B | -- | 0.41B | 0.43B | 3 |
| FQ4 2026 (Oct 2026) | 0.32B | -- | 0.31B | 0.32B | 2 |
| FQ3 2026 (Jul 2026) | 0.31B | -15.58 | 0.31B | 0.32B | 2 |
| FQ2 2026 (Jun 2026) | 0.39B | 9.71 | 0.37B | 0.4B | 3 |
| FQ1 2026 (Mar 2026) | 0.37B | 9.88 | 0.36B | 0.38B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.335 | 1.22 | -0.115 | -9.43% |
| FQ2 2025 (Jun 2025) | 1.3125 | 1.2 | -0.1125 | -9.38% |
| FQ1 2025 (Mar 2025) | 1.16 | 1.16 | 100% | |
| FQ4 2024 (Dec 2024) | 1.07 | 1.07 | 100% | |
| FQ3 2024 (Sep 2024) | 1.18 | 1.18 | 100% | |
| FQ2 2024 (Jun 2024) | 1.12 | 1.12 | 100% | |
| FQ1 2024 (Mar 2024) | 0.99 | 0.99 | 100% | |
| FQ4 2023 (Dec 2023) | 1.2 | 1.2 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.3B | $0.36B | $63.33M | 17.48% |
| FQ2 2025 (Jun 2025) | $0.3B | $0.35B | $49.74M | 14.23% |
| FQ1 2025 (Mar 2025) | $0B | $0.34B | $337.71M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.3B | $297.14M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.29B | $289.79M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.29B | $286.92M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.28B | $280.75M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.28B | $276.35M | 100% |